CSS LLC’s Japer Therapeutics Warrants JSPRW Stock Holding History

CSS LLC’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-81,957	Closed	-$6.56K	–	882
2023 Q4	$6.56K	Hold	81,957	–	–	﹤0.01%	766
2023 Q3	$4.1K	Hold	81,957	–	–	﹤0.01%	783
2023 Q2	$11.5K	Hold	81,957	–	–	﹤0.01%	834
2023 Q1	$16.4K	Buy	+81,957	New	+$12K	﹤0.01%	650

Other funds holding JSPRW

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS LLC's JSPRW Position: Q1 2024 in Review

CSS LLC sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2024, closing a stake of 81,957 shares — an estimated $6.56K sold.

CSS LLC first reported a position in JSPRW in Q1 2023 and held it in 4 quarters. The position peaked at $16.4K in Q1 2023. 4 funds tracked by Wall St. Rank hold JSPRW as of Q1 2024.

CSS LLC reported no remaining Japer Therapeutics Warrants position as of Q1 2024 after selling out during the quarter.
CSS LLC sold 81,957 Japer Therapeutics Warrants shares in Q1 2024, an estimated $6.56K.
CSS LLC first reported a position in Japer Therapeutics Warrants in Q1 2023 and held it in 4 quarters.
CSS LLC's Japer Therapeutics Warrants position peaked at $16.4K in Q1 2023.
4 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2024.

Based on CSS LLC's 13F filing for Q1 2024, filed 15 May 2024.